title: Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII).
authors.forename: L A
authors.initials: LA
authors.lastname: González
authors.forename: G J
authors.initials: GJ
authors.lastname: Pons-Estel
authors.forename: J S
authors.initials: JS
authors.lastname: Zhang
authors.forename: G
authors.initials: G
authors.lastname: McGwin
authors.forename: J
authors.initials: J
authors.lastname: Roseman
authors.forename: J D
authors.initials: JD
authors.lastname: Reveille
authors.forename: L M
authors.initials: LM
authors.lastname: Vilá
authors.forename: G S
authors.initials: GS
authors.lastname: Alarcón
mesh_terms: D000328:Adult; D001741:Black or African American; D000367:Age Factors; D015331:Cohort Studies; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000473:pathology; D008593:Menopause; D017058:Mexican Americans; D008875:Middle Aged; D016649:Primary Ovarian Insufficiency; D012307:Risk Factors; D012720:Severity of Illness Index; D014481:United States; D044465:White People
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide